Executive Conversation with Robert Wolfarth - Regualtory Affairs strategies part 2

SSI Executive Conversations by Darwin Shurig

Episode notes

On this next SSI Executive Conversation episode, Darwin and Robert explore the nuances of regulatory pathways in the medical industry. They dissect critical insights, including the need to avoid a transactional approach in regulatory processes and the importance of strategic planning to mitigate risks. The podcast sheds light on the high rate of FDA rejections for 510K applications and emphasizes the significance of emotional intelligence in regulatory professionals for successful submissions. Furthermore, considerations between consulting and full-time positions within the RA career path.

You can contact Robert at www.CadenceRegulatory.com

#RegulatoryInsights #MedicalIndustry #StrategicPlanning